Nucleic Acid Testing Market

Nucleic Acid Testing Market: Nucleic Acid Testing Kits Dominate Led by PCR; High Costs Remain a Key Factor Hampering Adoption in Long Run: Global Industry Analysis 2012 -2016 and Opportunity Assessment 2017 - 2027

Ask The Analyst Customization Available Request Methodology

Nucleic Acid Test Kits to Witness Resilient Growth

Nucleic acid testing is widely used to treat infectious diseases caused by virus and bacteria, forensic testing, cancerous diseases, genetically related diseases and paternity testing/HLA typing. The convenience it offers makes it one of the highly preferred testing procedures in the healthcare industry. Nucleic acid tests help in identifying the issue without any previous indications, in addition to offering an additional layer of blood screening and resolving false reactive interpretations. Furthermore, it is an early detection process and is known to provide accurate analysis - faster than any other available procedure, and helps to narrow down infectious period, i.e. window period between the time of viral exposure and the time of serological detection of a virus.

Increasing demand for nucleic acid testing form blood transfusion centers and blood banks will substantially secure the entire blood transfusion processes, which is anticipated to bolster the growth of the global nucleic acid testing market over the forecast period. The global market value is foreseen to reach beyond US$ 4,900 Mn by 2027 end. The market is lucrative, especially for nucleic acid test kits, which is dominated by high demand for polymerase chain reaction (PCR) in the global market. The PCR segment is expected to hold a market value of over US$ 2,300 Mn by the end of 2027, and a cumulative value for the nucleic acid test kits segment is estimated at over US$ 4,400 Mn by the end of forecast period.

nucleic-acid-testing.jpg

Various factors are responsible for forming a favorable market environment for nucleic acid test products

Numerous forces are driving the growth of demand for nucleic acid testing products, which majorly includes the surge in rate of technological development in the healthcare industry. Several companies with extensive product offerings have developed in-house capabilities to generate high-quality products with short turn-around times to meet varying research requirements. Increasing demand for technologically advanced methods in sample preparation, extraction, and amplification and testing for nucleic acids such as DNA and RNA, and the strategic agreements of manufacturers with leading research institutes are expected to boost research activities in the molecular biology field. There is also a broadened scope of nucleic acid testing application globally, as manufacturers of molecular diagnosis devices and kits have been developing several products with the capability to be used in both clinical diagnostics as well as research applications. The increasing demand for  advanced technology-based kits in various diagnostic aspects such as infectious diseases, cancer, forensic testing, paternity testing or HLA typing, turns to be the most effective force to facilitate to growth of nucleic acid testing market.

Safety concerns remain longstanding hurdle in market growth

The nucleic acid testing market still faces some limitations in its global demand surge. One of it is the safety concerns associated with the process.The adverse events and false operative functionality associated with the nucleic acid testing kits and reagents may hamper the demand for the product and restrain the growth of the nucleic acid testing market over the forecast period. A few emerging economies lack sophisticated infrastructure required for advanced technologies like nucleic acid testing. The improper development and implementation of clinical practice guidelines and dearth of skilled professionals in most of the countries, such as those in MEA and Latin America, will possibly continue to hinder the growth of the nucleic acid testing market.

Nucleic Acid Testing Market

This is an all-inclusive research report based on the facts gathered form different sections of the market. To get the accurate assessment, there has been a keen examination of healthcare industry worldwide, technological advancements taking place in the healthcare industry and also the account of patients and businesses involved in providing healthcare services. The report also comprises preferences of patients and doctors across the globe, which helps in accessing the current as well as future demand of the nucleic acid testing market. Further, analysis of awareness about the services in different regions has proved to be a useful information to process the research on global market for nucleic acid testing market.

Global Healthcare Services Sector Outlook

There is growing consensus among healthcare providers that the current fee-for-services payment mechanism needs an overhaul. While fee-for-services is the pervasive method of billing patients, alternative processes, such as capitation and pay-for-performance are also being considered. We anticipate fee-for-services to be supplemented by capitation and pay-for-performance in the future. In addition to charging patients for screening and doctor visits, pay-for-performance can lead to higher quality of care, as other essential tasks will also be billed. It may lead to an increase in healthcare costs, with the promise that quality of care will go up.

The healthcare system is in a phase where access to capital is constantly diminishing. Big spends are rare and there is increasing uncertainty among borrowers about their ability to repay loans and funding. Healthcare institutions are either postponing large capital-intensive projects or allocating resources to specialty areas that offer a high ROI. Cash-constraints will result into an increase in mergers and acquisitions and lead to fundraising from healthcare providers. However, as only a select few will qualify for an acquisition or funding, the effects of cash-crunch will be palpable in this sector.

Healthcare providers and insurers are aware of the rapidly increasingly population and their growing healthcare needs. The impact is more palpable in the U.S. and Japan – important markets in terms of their standing in the global healthcare market. Providers and insurers are strategizing to tap into the available opportunities in this demographic. Baby boomers around the globe are actively taking charge of their health. Smartphone remains the primary source of information-seeking for this segment. With over 70,000 websites and hundreds of apps disseminating information, providers and insurers will focus on strengthening their digital presence to effectively target this demographic.

Research Methodology

FMI utilizes robust methodology and approach to arrive at market size and related projections. The research methodology for this report is based on 3 dimensional model. We conduct about 45-60 min duration detailed interviews with product manufacturers; apart from this we also collect market feedback from industry experts. To validate this data, we interact with senior panel members having more than 10 years of experience in relevant field. The panel members help in validating the findings and fill the gaps if any.  In addition, we leverage on our existing pool of information, paid database and other valid information sources available in public domain. Usually industry interactions extend to more than 50+ interviews from market participants across the value chain.

Data Collection

FMI collects data from secondary sources including company annual reports, association publications, industry presentations, white papers, and company press releases apart from these we leverage over paid database subscriptions and industry magazines to collect market information and developments in exhaustive manner. After being done with desk research, detailed questionnaire and discussion guide is formulated to initiate primary research with key industry personnel; the discussion aims at collecting key insights, growth perspectives, prevalent market trends and quantitative insights including market size and competition developments. Both of these research approaches help us in arriving at base year numbers and market hypothesis.

Market Taxonomy

By Product Type

By Indication

By End User

By Region

  • Nucleic Acid test Kits

    • Transcription-mediated amplification (TMA)

    • Polymerase chain reaction (PCR)

    • Ligase chain reaction (LCR)

    • Whole genome  sequencing

  •  Consumables

  • Infectious diseases

  • Cancer

  • Forensic Testing

  • Others

  • Hospitals

  • Pathology laboratories

  • Research Institutes

  • Clinics

  • North America

  • Latin America

  • Western Europe

  • Eastern Europe

  • APECJ

  • China

  • Japan

  • MEA

Nucleic Acid Testing Market Reports - Table of Contents

1. Executive Summary

1.1. Market Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Taxonomy

2.2. Market Definition

2.3. Company Description and Nucleic Acid Testing Market Research Coverage

3. Nucleic Acid Testing Market Opportunity Analysis

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

4. Global Economic Outlook

4.1. Global Gross Domestic Product by Region & Country

4.2. Nucleic Acid Testing Market Outlook

5. Market Background

5.1. List of Growth Hacking Manufacturers

5.2. Market Dynamics

5.2.1. Drivers

5.2.2. Restraints

5.3. Regional Pricing Analysis

6. Macroeconomic Assumptions

7. North America Nucleic Acid Testing Market Analysis 2012–2016 and Forecast 2017–2027

7.1. Introduction

7.2. Regional Market Trends

7.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

7.3.1. U.S.

7.3.2. Canada

7.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

7.4.1. U.S.

7.4.2. Canada

7.5. Historical Market Size (US$ Mn) Analysis By Product Type , 2012-2016

7.5.1. Nucleic Acid test Kits

7.5.1.1. Transcription –mediated amplification (TMA)

7.5.1.2. Polymerase chain reaction (PCR)

7.5.1.3. Ligase chain reaction (LCR)

7.5.1.4. Whole genome sequencing

7.5.2. Consumables

7.6. Market Size (US$ Mn) Forecast By Product Type , 2017-2027

7.7. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2012-2016

7.7.1. Infectious diseases

7.7.2. Cancer

7.7.3. Forensic Testing

7.7.4. Others

7.8. Market Size (US$ Mn) Forecast By Indication, 2017-2027

7.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012-2016

7.9.1. Hospitals

7.9.2. Pathology laboratories

7.9.3. Research Institutes

7.9.4. Clinics

7.10.Market Size (US$ Mn) Forecast By End User, 2017-2027

7.11.Drivers and Restraints: Impact Analysis

7.12.Market Attractiveness Analysis

7.12.1. By Country

7.12.2. By Product Type

7.12.3. By Indication

7.12.4. By End user

7.13.Key Market Participants – Intensity Mapping

7.14.Key Mergers & Acquisitions

8. Western Europe Nucleic Acid Testing Market Analysis 2012–2016 and Forecast 2017–2027

8.1. Introduction

8.2. Regional Market Trends

8.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

8.3.1. Germany

8.3.2. U.K

8.3.3. France

8.3.4. Italy

8.3.5. Spain

8.3.6. Rest of Western Europe

8.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

8.4.1. Germany

8.4.2. U.K

8.4.3. France

8.4.4. Italy

8.4.5. Spain

8.4.6. Rest of Western Europe

8.5. Historical Market Size (US$ Mn) Analysis By Product Type , 2012-2016

8.5.1. Nucleic Acid test Kits

8.5.1.1. Transcription –mediated amplification (TMA)

8.5.1.2. Polymerase chain reaction (PCR)

8.5.1.3. Ligase chain reaction (LCR)

8.5.1.4. Whole genome sequencing

8.5.2. Consumables

8.6. Market Size (US$ Mn) Forecast By Product Type , 2017-2027

8.7. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2012-2016

8.7.1. Infectious diseases

8.7.2. Cancer

8.7.3. Forensic Testing

8.7.4. Others

8.8. Market Size (US$ Mn) Forecast By Indication, 2017-2027

8.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012-2016

8.9.1. Hospitals

8.9.2. Pathology laboratories

8.9.3. Research Institutes

8.9.4. Clinics

8.10.Market Size (US$ Mn) Forecast By End User, 2017-2027

8.11.Drivers and Restraints: Impact Analysis

8.12.Market Attractiveness Analysis

8.12.1. By Country

8.12.2. By Product Type

8.12.3. By Indication

8.12.4. By End user

8.13.Key Market Participants – Intensity Mapping

8.14.Key Mergers & Acquisitions

9. Eastern Europe Nucleic Acid Testing Market Analysis 2012–2016 and Forecast 2017–2027

9.1. Introduction

9.2. Regional Market Trends

9.3. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

9.3.1. Russia

9.3.2. Poland

9.3.3. Rest of Eastern Europe

9.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

9.4.1. Russia

9.4.2. Poland

9.4.3. Rest of Eastern Europe

9.5. Historical Market Size (US$ Mn) Analysis By Product Type , 2012-2016

9.5.1. Nucleic Acid test Kits

9.5.1.1. Transcription –mediated amplification (TMA)

9.5.1.2. Polymerase chain reaction (PCR)

9.5.1.3. Ligase chain reaction (LCR)

9.5.1.4. Whole genome sequencing

9.5.2. Consumables

9.6. Market Size (US$ Mn) Forecast By Product Type , 2017-2027

9.7. Historical Market Size (US$ Mn) Trend Analysis By Indication, 2012-2016

9.7.1. Infectious diseases

9.7.2. Cancer

9.7.3. Forensic Testing

9.7.4. Others

9.8. Market Size (US$ Mn) Forecast By Indication, 2017-2027

9.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012-2016

9.9.1. Hospitals

9.9.2. Pathology laboratories

9.9.3. Research Institutes

9.9.4. Clinics

9.10.Market Size (US$ Mn) Forecast By End User, 2017-2027

9.11.Drivers and Restraints: Impact Analysis

9.12.Market Attractiveness Analysis

9.12.1. By Country

9.12.2. By Product Type

9.12.3. By Indication

9.12.4. By End user

9.13.Key Market Participants – Intensity Mapping

9.14.Key Mergers & Acquisitions

10. Latin America Nucleic Acid Testing Market Analysis 2012–2016 and Forecast 2017–2027

10.1.Introduction

10.2.Regional Market Trends

10.3.Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

10.3.1. Brazil

10.3.2. Mexico

10.3.3. Rest of Latin America

10.4.Market Size (US$ Mn) Forecast By Country, 2017-2027

10.4.1. Brazil

10.4.2. Mexico

10.4.3. Rest of Latin America

10.5.Historical Market Size (US$ Mn) Analysis By Product Type , 2012-2016

10.5.1. Nucleic Acid test Kits

10.5.1.1. Transcription –mediated amplification (TMA)

10.5.1.2. Polymerase chain reaction (PCR)

10.5.1.3. Ligase chain reaction (LCR)

10.5.1.4. Whole genome sequencing

10.5.2. Consumables

10.6.Market Size (US$ Mn) Forecast By Product Type , 2017-2027

10.7.Historical Market Size (US$ Mn) Trend Analysis By Indication, 2012-2016

10.7.1. Infectious diseases

10.7.2. Cancer

10.7.3. Forensic Testing

10.7.4. Others

10.8.Market Size (US$ Mn) Forecast By Indication, 2017-2027

10.9.Historical Market Size (US$ Mn) Trend Analysis By End User, 2012-2016

10.9.1. Hospitals

10.9.2. Pathology laboratories

10.9.3. Research Institutes

10.9.4. Clinics

10.10. Market Size (US$ Mn) Forecast By End User, 2017-2027

10.11. Drivers and Restraints: Impact Analysis

10.12. Market Attractiveness Analysis

10.12.1. By Country

10.12.2. By Product Type

10.12.3. By Indication

10.12.4. By End user

10.13. Key Market Participants – Intensity Mapping

10.14. Key Mergers & Acquisitions

11. Asia Pacific Excluding China & Japan Nucleic Acid Testing Market Analysis 2012–2016 and Forecast 2017–2027

11.1.Introduction

11.2.Regional Market Trends

11.3.Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

11.3.1. India

11.3.2. Australia and New Zealand

11.3.3. ASEAN

11.3.4. Rest of APECJ

11.4.Market Size (US$ Mn) Forecast By Country, 2017-2027

11.4.1. India

11.4.2. Australia and New Zealand

11.4.3. ASEAN

11.4.4. Rest of APECJ

11.5.Historical Market Size (US$ Mn) Analysis By Product Type , 2012-2016

11.5.1. Nucleic Acid test Kits

11.5.1.1. Transcription –mediated amplification (TMA)

11.5.1.2. Polymerase chain reaction (PCR)

11.5.1.3. Ligase chain reaction (LCR)

11.5.1.4. Whole genome sequencing

11.5.2. Consumables

11.6.Market Size (US$ Mn) Forecast By Product Type , 2017-2027

11.7.Historical Market Size (US$ Mn) Trend Analysis By Indication, 2012-2016

11.7.1. Infectious diseases

11.7.2. Cancer

11.7.3. Forensic Testing

11.7.4. Others

11.8.Market Size (US$ Mn) Forecast By Indication, 2017-2027

11.9.Historical Market Size (US$ Mn) Trend Analysis By End User, 2012-2016

11.9.1. Hospitals

11.9.2. Pathology laboratories

11.9.3. Research Institutes

11.9.4. Clinics

11.10. Market Size (US$ Mn) Forecast By End User, 2017-2027

11.11. Drivers and Restraints: Impact Analysis

11.12. Market Attractiveness Analysis

11.12.1. By Country

11.12.2. By Product Type

11.12.3. By Indication

11.12.4. By End user

11.13. Key Market Participants – Intensity Mapping

11.14. Key Mergers & Acquisitions

12. China Nucleic Acid Testing Market Analysis 2012–2016 and Forecast 2017–2027

12.1.Introduction

12.2.Market Trends

12.3.Historical Market Size (US$ Mn) Analysis By Product Type , 2012-2016

12.3.1. Nucleic Acid test Kits

12.3.1.1. Transcription –mediated amplification (TMA)

12.3.1.2. Polymerase chain reaction (PCR)

12.3.1.3. Ligase chain reaction (LCR)

12.3.1.4. Whole genome sequencing

12.3.2. Consumables

12.4.Market Size (US$ Mn) Forecast By Product Type , 2017-2027

12.5.Historical Market Size (US$ Mn) Trend Analysis By Indication, 2012-2016

12.5.1. Infectious diseases

12.5.2. Cancer

12.5.3. Forensic Testing

12.5.4. Others

12.6.Market Size (US$ Mn) Forecast By Indication, 2017-2027

12.7.Historical Market Size (US$ Mn) Trend Analysis By End User, 2012-2016

12.7.1. Hospitals

12.7.2. Pathology laboratories

12.7.3. Research Institutes

12.7.4. Clinics

12.8.Market Size (US$ Mn) Forecast By End User, 2017-2027

12.9.Drivers and Restraints: Impact Analysis

12.10. Market Attractiveness Analysis

12.10.1. By Country

12.10.2. By Product Type

12.10.3. By Indication

12.10.4. By End user

12.11. Key Market Participants – Intensity Mapping

12.12. Key Mergers & Acquisitions

13. Japan Nucleic Acid Testing Market Analysis 2012–2016 and Forecast 2017–2027

13.1.Introduction

13.2.Market Trends

13.3.Historical Market Size (US$ Mn) Analysis By Product Type , 2012-2016

13.3.1. Nucleic Acid test Kits

13.3.1.1. Transcription –mediated amplification (TMA)

13.3.1.2. Polymerase chain reaction (PCR)

13.3.1.3. Ligase chain reaction (LCR)

13.3.1.4. Whole genome sequencing

13.3.2. Consumables

13.4.Market Size (US$ Mn) Forecast By Product Type , 2017-2027

13.5.Historical Market Size (US$ Mn) Trend Analysis By Indication, 2012-2016

13.5.1. Infectious diseases

13.5.2. Cancer

13.5.3. Forensic Testing

13.5.4. Others

13.6.Market Size (US$ Mn) Forecast By Indication, 2017-2027

13.7.Historical Market Size (US$ Mn) Trend Analysis By End User, 2012-2016

13.7.1. Hospitals

13.7.2. Pathology laboratories

13.7.3. Research Institutes

13.7.4. Clinics

13.8.Market Size (US$ Mn) Forecast By End User, 2017-2027

13.9.Drivers and Restraints: Impact Analysis

13.10. Market Attractiveness Analysis

13.10.1. By Country

13.10.2. By Product Type

13.10.3. By Indication

13.10.4. By End user

13.11. Key Market Participants – Intensity Mapping

13.12. Key Mergers & Acquisitions

14. Middle East and Africa Nucleic Acid Testing Market Analysis 2012–2016 and Forecast 2017–2027

14.1.Introduction

14.2.Regional Market Trends

14.3.Historical Market Size (US$ Mn) Analysis By Country, 2012-2016

14.3.1. GCC Countries

14.3.2. South Africa

14.3.3. Rest of Middle East and Africa

14.4.Market Size (US$ Mn) Forecast By Country, 2017-2027

14.4.1. GCC Countries

14.4.2. South Africa

14.4.3. Rest of Middle East and Africa

14.5.Historical Market Size (US$ Mn) Analysis By Product Type , 2012-2016

14.5.1. Nucleic Acid test Kits

14.5.1.1. Transcription –mediated amplification (TMA)

14.5.1.2. Polymerase chain reaction (PCR)

14.5.1.3. Ligase chain reaction (LCR)

14.5.1.4. Whole genome sequencing

14.5.2. Consumables

14.6.Market Size (US$ Mn) Forecast By Product Type , 2017-2027

14.7.Historical Market Size (US$ Mn) Trend Analysis By Indication, 2012-2016

14.7.1. Infectious diseases

14.7.2. Cancer

14.7.3. Forensic Testing

14.7.4. Others

14.8.Market Size (US$ Mn) Forecast By Indication, 2017-2027

14.9.Historical Market Size (US$ Mn) Trend Analysis By End User, 2012-2016

14.9.1. Hospitals

14.9.2. Pathology laboratories

14.9.3. Research Institutes

14.9.4. Clinics

14.10. Market Size (US$ Mn) Forecast By End User, 2017-2027

14.11. Drivers and Restraints: Impact Analysis

14.12. Market Attractiveness Analysis

14.12.1. By Country

14.12.2. By Product Type

14.12.3. By Indication

14.12.4. By End user

14.13. Key Market Participants – Intensity Mapping

14.14. Key Mergers & Acquisitions

15. Forecast Factors: Relevance and Impact

16. Forecast Assumptions

17. Market Structure Analysis

17.1.Market Structure by Tier of Companies

17.2.Market Share Analysis (2016) for Top 10 Players, By Region

18. Competition Analysis

18.1.Competition Dashboard

18.2.Profitability and Gross Margin Analysis By Competition

18.3.Company Deep Dive

18.3.1. Agilent Technologies

18.3.1.1. Overview

18.3.1.2. Product and Application Portfolio

18.3.1.3. Production Footprint

18.3.1.4. Sales Footprint

18.3.1.5. Channel Footprint

18.3.1.6. Strategy

18.3.1.6.1. Marketing Strategy

18.3.1.6.2. Product Strategy

18.3.1.6.3. Channel Strategy

18.3.2. Danaher Corporation

18.3.2.1. Overview

18.3.2.2. Product and Application Portfolio

18.3.2.3. Production Footprint

18.3.2.4. Sales Footprint

18.3.2.5. Channel Footprint

18.3.2.6. Strategy

18.3.2.6.1. Marketing Strategy

18.3.2.6.2. Product Strategy

18.3.2.6.3. Channel Strategy

18.3.3. Abbott Laboratories, Inc.

18.3.3.1. Overview

18.3.3.2. Product and Application Portfolio

18.3.3.3. Production Footprint

18.3.3.4. Sales Footprint

18.3.3.5. Channel Footprint

18.3.3.6. Strategy

18.3.3.6.1. Marketing Strategy

18.3.3.6.2. Product Strategy

18.3.3.6.3. Channel Strategy

18.3.4. Becton, Dickinson and Company

18.3.4.1. Overview

18.3.4.2. Product and Application Portfolio

18.3.4.3. Production Footprint

18.3.4.4. Sales Footprint

18.3.4.5. Channel Footprint

18.3.4.6. Strategy

18.3.4.6.1. Marketing Strategy

18.3.4.6.2. Product Strategy

18.3.4.6.3. Channel Strategy

18.3.5. Bio-Rad Laboratories, Inc.

18.3.5.1. Overview

18.3.5.2. Product and Application Portfolio

18.3.5.3. Production Footprint

18.3.5.4. Sales Footprint

18.3.5.5. Channel Footprint

18.3.5.6. Strategy

18.3.5.6.1. Marketing Strategy

18.3.5.6.2. Product Strategy

18.3.5.6.3. Channel Strategy

18.3.6. F. Hoffmann-La Roche Ltd.

18.3.6.1. Overview

18.3.6.2. Product and Application Portfolio

18.3.6.3. Production Footprint

18.3.6.4. Sales Footprint

18.3.6.5. Channel Footprint

18.3.6.6. Strategy

18.3.6.6.1. Marketing Strategy

18.3.6.6.2. Product Strategy

18.3.6.6.3. Channel Strategy

18.3.7. Illumina, Inc.

18.3.7.1. Overview

18.3.7.2. Product and Application Portfolio

18.3.7.3. Production Footprint

18.3.7.4. Sales Footprint

18.3.7.5. Channel Footprint

18.3.7.6. Strategy

18.3.7.6.1. Marketing Strategy

18.3.7.6.2. Product Strategy

18.3.7.6.3. Channel Strategy

18.3.8. Thermo Fisher Scientific Inc.

18.3.8.1. Overview

18.3.8.2. Product and Application Portfolio

18.3.8.3. Production Footprint

18.3.8.4. Sales Footprint

18.3.8.5. Channel Footprint

18.3.8.6. Strategy

18.3.8.6.1. Marketing Strategy

18.3.8.6.2. Product Strategy

18.3.8.6.3. Channel Strategy

18.3.9. Merck KGaA,

18.3.9.1. Overview

18.3.9.2. Product and Application Portfolio

18.3.9.3. Production Footprint

18.3.9.4. Sales Footprint

18.3.9.5. Channel Footprint

18.3.9.6. Strategy

18.3.9.6.1. Marketing Strategy

18.3.9.6.2. Product Strategy

18.3.9.6.3. Channel Strategy

18.3.10. Qiagen

18.3.10.1. Overview

18.3.10.2. Product and Application Portfolio

18.3.10.3. Production Footprint

18.3.10.4. Sales Footprint

18.3.10.5. Channel Footprint

18.3.10.6. Strategy

18.3.10.6.1. Marketing Strategy

18.3.10.6.2. Product Strategy

18.3.10.6.3. Channel Strategy

19. Global Nucleic Acid Testing Market Analysis 2012–2016 and Forecast 2017–2027 By Region

19.1.Introduction / Key Findings

19.2.Historical Market Size (US$ Mn) Analysis By Region

19.2.1. North America

19.2.2. Western Europe

19.2.3. Eastern Europe

19.2.4. Latin America

19.2.5. Asia Pacific Excluding Japan

19.2.6. Japan

19.2.7. Middle East and Africa

19.3.Market Size (US$ Mn) Forecast By Region

19.3.1. North America

19.3.2. Western Europe

19.3.3. Eastern Europe

19.3.4. Latin America

19.3.5. Asia Pacific Excluding Japan

19.3.6. Japan

19.3.7. Middle East and Africa

19.4.Market Attractiveness Analysis By Region

20. Global Nucleic Acid Testing Market Analysis 2012–2016 and Forecast 2017–2027, By Product Type

20.1.Introduction/Key Finding

20.2.Historical Market Size (US$ Mn) Trend Analysis By Product Type , 2012-2016

20.2.1. Nucleic Acid test Kits

20.2.1.1. Transcription –mediated amplification (TMA)

20.2.1.2. Polymerase chain reaction (PCR)

20.2.1.3. Ligase chain reaction (LCR)

20.2.1.4. Nucleic acid sequence –based amplification.

20.2.1.5. Whole genome sequencing

20.2.2. Consumables

20.3.Market Size (US$ Mn) Forecast By Product Type , 2017-2027

20.4.Market Attractiveness Analysis By Product Type

21. Global Nucleic Acid Testing Market Analysis 2012–2016 and Forecast 2017–2027, By Indication

21.1.Introduction/Key Finding

21.2.Historical Market Size (US$ Mn) Trend Analysis By Indication, 2012-2016

21.2.1. Infectious diseases

21.2.2. Cancer

21.2.3. Forensic Testing

21.2.4. Paternity Testing/HLA Typing

21.2.5. Others

21.3.Market Size (US$ Mn) Forecast By Indication, 2017-2027

21.4.Market Attractiveness Analysis By Indication

22. Global Nucleic Acid Testing Market Analysis 2012–2016 and Forecast 2017–2027, By End User

22.1.Introduction/Key Finding

22.2.Historical Market Size (US$ Mn) Trend Analysis By End User, 2012-2016

22.2.1. Hospitals

22.2.2. Pathology laboratories

22.2.3. Research Institutes

22.2.4. Clinics

22.3.Market Size (US$ Mn) Forecast By End User, 2017-2027

22.4.Market Attractiveness Analysis By End User

23. Global Nucleic Acid Testing Market Analysis 2012–2016 and Forecast 2017–2027

23.1.Market Value Share Analysis

23.1.1. By Product Type

23.1.2. By Indication

23.1.3. By End user

23.2.Y-o-Y Growth Analysis

23.2.1. By Product Type

23.2.2. By Indication

23.2.3. By End user

23.3.Absolute $ Opportunity

24. Assumptions and Acronyms Used

25. Research Methodology

Nucleic Acid Testing Market Reports - List of Tables

Table 01: North America Nucleic Acid Testing Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 02: North America Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type

Table 03: North America Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Indication

Table 04: North America Nucleic Acid Testing Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By End User

Table 05: Latin America Nucleic Acid Testing Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 06: Latin America Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type

Table 07: Latin America Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Indication

Table 08: Latin America Nucleic Acid Testing Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By End User

Table 09: Western Europe Nucleic Acid Testing Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 10: Western Europe Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type

Table 11: Western Europe Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Indication

Table 12: Western Europe Nucleic Acid Testing Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By End User

Table 13: Eastern Europe Nucleic Acid Testing Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 14: Eastern Europe Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type

Table 15: Eastern Europe Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Indication

Table 16: Eastern Europe Nucleic Acid Testing Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By End User

Table 17: APECJ Nucleic Acid Testing Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 18: APECJ Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type

Table 19: APECJ Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Indication

Table 20: APECJ Nucleic Acid Testing Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By End User

Table 21: China Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type

Table 22: China Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Indication

Table 23: China Nucleic Acid Testing Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By End User

Table 24: Japan Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type

Table 25: Japan Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Indication

Table 26: Japan Nucleic Acid Testing Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By End User

Table 27: MEA Nucleic Acid Testing Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country

Table 28: MEA Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type

Table 29: MEA Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Indication

Table 30: MEA Nucleic Acid Testing Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By End User

Table 31: Global Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Region

Table 32: Global Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Product Type

Table 33: Global Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Indication

Table 34: Global Nucleic Acid Testing Market Size Value (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By End User

Nucleic Acid Testing Market Reports - List of Figures

Figure 01: Global Nucleic Acid Testing Market Value Share By Product Type 2016 (A)

Figure 02: Global Nucleic Acid Testing Market Value (US$ Mn) By Indication, 2016 (A)

Figure 03: Global Nucleic Acid Testing Market Value Share By End User, 2016 (A)

Figure 04: Global Nucleic Acid Testing Market Value Share By Region, 2016 (A)

Figure 05: Nucleic Acid Testing kit, Price Difference (US$) By Region, 2016

Figure 06: Nucleic Acid Testing kit, Price Difference (US$) By Region, 2027

Figure 07: Global Healthcare Expenditure in US$ Tn (2013–2020)

Figure 08: North America Nucleic Acid Testing Market Size Analysis, 2012–2016

Figure 09: North America Nucleic Acid Testing Market Forecast, 2017–2027

Figure 10: U.S. Nucleic Acid Testing Market Size Analysis, 2012–2016

Figure 11: U.S. Nucleic Acid Testing Market Forecast, 2017–2027

Figure 12: Canada Nucleic Acid Testing Market Size Analysis, 2012–2016

Figure 13: Canada Nucleic Acid Testing Market Forecast, 2017–2027

Figure 14: North America Nucleic Acid Testing Market Size (US$) Analysis, By Nucleic Acid test Kits, 2012–2016

Figure 15: North America Nucleic Acid Testing Market Forecast, By Nucleic Acid test Kits, 2017–2027

Figure 16: North America Nucleic Acid Testing Market Size Analysis, By Consumables ,2012–2016

Figure 17: North America Nucleic Acid Testing Market Forecast, By Consumables, 2017–2027

Figure 18: North America Nucleic Acid Testing Market Size Analysis, By Infectious Diseases, 2012–2016

Figure 19: North America Nucleic Acid Testing Market Forecast, By Infectious Diseases, 2017–2027

Figure 20: North America Nucleic Acid Testing Market Size Analysis, By Cancer ,2012–2016

Figure 21: North America Nucleic Acid Testing Market Forecast, By Cancer, 2017–2027

Figure 22: North America Nucleic Acid Testing Market Size Analysis, By Forensic Testing 2012–2016

Figure 23: North America Nucleic Acid Testing Market Forecast, By Forensic Testing, 2017–2027

Figure 24: North America Nucleic Acid Testing Market Size Analysis, By Other Indications, 2012–2016

Figure 25: North America Nucleic Acid Testing Market Size Analysis, By Other Indications, 2017–2027

Figure 26: North America Nucleic Acid Testing Market Size Analysis, By Hospitals, 2012–2016

Figure 27: North America Nucleic Acid Testing Market Forecast, By Hospitals, 2017–2027

Figure 28: North America Nucleic Acid Testing Market Size Analysis, By Pathology Laboratories, 2012–2016

Figure 29: North America Nucleic Acid Testing Market Forecast, By Pathology Laboratories, 2017–2027

Figure 30: North America Nucleic Acid Testing Market Size Analysis, By Research Institutes, 2012–2016

Figure 31: North America Nucleic Acid Testing Market Forecast, By Research Institutes, 2017–2027

Figure 32: North America Nucleic Acid Testing Market Size Analysis, By Clinics, 2012–2016

Figure 33: North America Nucleic Acid Testing Market Forecast, By Clinics, 2017–2027

Figure 34: North America Nucleic Acid Testing Market Attractiveness Analysis, By Country

Figure 35: North Nucleic Acid Testing Market Attractiveness Analysis, By Product Type

Figure 36: North Nucleic Acid Testing Market Attractiveness Analysis, By Indication

Figure 37: North Nucleic Acid Testing Market Attractiveness Analysis, By End User

Figure 38: Latin America Nucleic Acid Testing Market Size Analysis, 2012–2016

Figure 39: Latin America Nucleic Acid Testing Market Forecast, 2017–2027

Figure 40: Brazil Nucleic Acid Testing Market Size Analysis, 2012–2016

Figure 41: Brazil Nucleic Acid Testing Market Forecast, 2017–2027

Figure 42: Mexico Nucleic Acid Testing Market Size Analysis, 2012–2016

Figure 43: Mexico Nucleic Acid Testing Market Forecast, 2017–2027

Figure 44: Rest of Latin America Centers Nucleic Acid Testing Market Size Analysis, 2012–2016

Figure 45: Rest of Latin America Centers Nucleic Acid Testing Market Size Analysis, 2017–2027

Figure 46: Latin America Nucleic Acid Testing Market Size Analysis, By Nucleic Acid test Kits, 2012–2016

Figure 47: Latin America Nucleic Acid Testing Market Forecast, By Nucleic Acid test Kits, 2017–2027

Figure 48: Latin America Nucleic Acid Testing Market Size Analysis, By Consumables, 2012–2016

Figure 49: Latin America Nucleic Acid Testing Market Forecast, By Consumables, 2017–2027

Figure 50: Latin America Nucleic Acid Testing Market Size Analysis, By Infectious Diseases, 2012–2016

Figure 51: Latin America Nucleic Acid Testing Market Forecast, By Infectious Diseases, 2017–2027

Figure 52: Latin America Nucleic Acid Testing Market Size Analysis, By Cancer, 2012–2016

Figure 53: Latin America Nucleic Acid Testing Market Forecast, By Cancer, 2017–2027

Figure 54: Latin America Nucleic Acid Testing Market Size Analysis, By Forensic Testing, 2012–2016

Figure 55: Latin America Nucleic Acid Testing Market Forecast, By Forensic Testing, 2017–2027

Figure 56: Latin America Nucleic Acid Testing Market Size Analysis, By Other Indications, 2012–2016

Figure 57: Latin America Nucleic Acid Testing Market Size Analysis, By Other Indications, 2017–2027

Figure 58: Latin America Nucleic Acid Testing Market Size Analysis, By Hospitals, 2012–2016

Figure 59: Latin America Nucleic Acid Testing Market Forecast, By Hospitals, 2017–2027

Figure 60: Latin America Nucleic Acid Testing Market Size Analysis, By Pathology Laboratories, 2012–2016

Figure 61: Latin America Nucleic Acid Testing Market Forecast, By Pathology Laboratories, 2017–2027

Figure 62: Latin America Nucleic Acid Testing Market Size Analysis, By Research Institutes, 2012–2016

Figure 63: Latin America Nucleic Acid Testing Market Forecast, By Research Institutes, 2017–2027

Figure 64: Latin America Nucleic Acid Testing Market Size Analysis, By Clinics, 2012–2016

Figure 65: Latin America Nucleic Acid Testing Market Forecast, By Clinics, 2017–2027

Figure 66: Latin America Nucleic Acid Testing Market Attractiveness Analysis, By Country

Figure 67: Latin Nucleic Acid Testing Market Attractiveness Analysis, By Product Type

Figure 68: Latin Nucleic Acid Testing Market Attractiveness Analysis, By Indication

Figure 69: Latin Nucleic Acid Testing Market Attractiveness Analysis, By End User

Figure 70: Western Europe Nucleic Acid Testing Market Size Analysis, 2012–2016

Figure 71: Western Europe Nucleic Acid Testing Market Forecast, 2017–2027

Figure 72: Germany Nucleic Acid Testing Market Size Analysis, 2012–2016

Figure 73: Germany Nucleic Acid Testing Market Forecast, 2017–2027

Figure 74: U.K. Nucleic Acid Testing Market Size Analysis, 2012–2016

Figure 75: U.K. Nucleic Acid Testing Market Forecast, 2017–2027

Figure 76: France Nucleic Acid Testing Market Size Analysis, 2012–2016

Figure 77: France Nucleic Acid Testing Market Forecast, 2017–2027

Figure 78: Italy Nucleic Acid Testing Market Size Analysis, 2012–2016

Figure 79: Italy Nucleic Acid Testing Market Forecast, 2017–2027

Figure 80: Spain Nucleic Acid Testing Market Size Analysis, 2012–2016

Figure 81: Spain Nucleic Acid Testing Market Forecast, 2017–2027

Figure 82: Rest of Western Europe Nucleic Acid Testing Market Size Analysis, 2012–2016

Figure 83: Rest of Western Europe Nucleic Acid Testing Market Forecast, 2017–2027

Figure 84: Western Europe Nucleic Acid Testing Market Size Analysis by Nucleic Acid test Kits, 2012–2016

Figure 85: Western Europe Nucleic Acid Testing Market Forecast by Nucleic Acid test Kits, 2017–2027

Figure 86: Western Europe Nucleic Acid Testing Market Size Analysis, by Consumables, 2012–2016

Figure 87: Western Europe Nucleic Acid Testing Market Forecast, by Consumables, 2017–2027

Figure 88: Western Europe Nucleic Acid Testing Market Size Analysis, By Infectious Diseases, 2012–2016

Figure 89: Western Europe Nucleic Acid Testing Market Forecast, By Infectious Diseases, 2017–2027

Figure 90: Western Europe Nucleic Acid Testing Market Size Analysis, By Cancer ,2012–2016

Figure 91: Western Europe Nucleic Acid Testing Market Forecast, By Cancer, 2017–2027

Figure 92: Western Europe Nucleic Acid Testing Market Size Analysis, By Forensic Testing 2012–2016

Figure 93: Western Europe Nucleic Acid Testing Market Forecast, By Forensic Testing, 2017–2027

Figure 94: Western Europe Nucleic Acid Testing Market Size Analysis, By Other Indications, 2012–2016

Figure 95: Western Europe Nucleic Acid Testing Market Size Analysis, By Other Indications, 2012–2016

Figure 96: Western Europe Nucleic Acid Testing Market Size Analysis, By Hospitals, 2012–2016

Figure 97: Western Europe Nucleic Acid Testing Market Forecast, By Hospitals, 2017–2027

Figure 98: Western Europe Nucleic Acid Testing Market Size Analysis, By Pathology Laboratories, 2012–2016

Figure 99: Western Europe Nucleic Acid Testing Market Forecast, By Pathology Laboratories, 2017–2027

Figure 100: Western Europe Nucleic Acid Testing Market Size Analysis, By Research Institutes, 2012–2016

Figure 101: Western Europe Nucleic Acid Testing Market Forecast, By Research Institutes, 2017–2027

Figure 102: Western Europe Nucleic Acid Testing Market Size Analysis, By Clinics, 2012–2016

Figure 103: Western Europe Nucleic Acid Testing Market Forecast, By Clinics, 2017–2027

Figure 104: Western Europe Nucleic Acid Testing Market Attractiveness Analysis, By Country

Figure 105: Latin Nucleic Acid Testing Market Attractiveness Analysis, By Product Type

Figure 106: Latin Nucleic Acid Testing Market Attractiveness Analysis, By Indication

Figure 107: Latin Nucleic Acid Testing Market Attractiveness Analysis, By End User

Figure 108: Eastern Europe Nucleic Acid Testing Market Size Analysis, 2012–2016

Figure 109: Eastern Europe Nucleic Acid Testing Market Forecast, 2017–2027

Figure 110: Russia Nucleic Acid Testing Market Size Analysis, 2012–2016

Figure 111: Russia Nucleic Acid Testing Market Forecast, 2017–2027

Figure 112: Poland Nucleic Acid Testing Market Size Analysis, 2012–2016

Figure 113: Poland Nucleic Acid Testing Market Forecast, 2017–2027

Figure 114: Rest of Eastern Europe Nucleic Acid Testing Market Size Analysis, 2012–2016

Figure 115: Rest of Eastern Europe Nucleic Acid Testing Market Size Analysis, 2017–2027

Figure 116: Eastern Europe Nucleic Acid Testing Market Size Analysis, by Nucleic Acid test Kits, 2012–2016

Figure 117: Eastern Europe Nucleic Acid Testing Market Forecast, by Nucleic Acid test Kits, 2017–2027

Figure 118: Eastern Europe Nucleic Acid Testing Market Size Analysis, by Consumables, 2012–2016

Figure 119: Eastern Europe Nucleic Acid Testing Market Forecast, by Consumables, 2017–2027

Figure 120: Eastern Europe Nucleic Acid Testing Market Size Analysis, by Infectious Diseases, 2012–2016

Figure 121: Eastern Europe Nucleic Acid Testing Market Forecast, by Infectious Diseases, 2017–2027

Figure 122: Eastern Europe Nucleic Acid Testing Market Size Analysis, by Cancer, 2012–2016

Figure 123: Eastern Europe Nucleic Acid Testing Market Forecast, by Cancer, 2017–2027

Figure 124: Eastern Europe Nucleic Acid Testing Market Size Analysis, by Forensic Testing, 2012–2016

Figure 125: Eastern Europe Nucleic Acid Testing Market Forecast, by Forensic Testing, 2017–2027

Figure 126: Eastern Europe Nucleic Acid Testing Market Size Analysis, by Others Indications, 2012–2016

Figure 127: Eastern Europe Nucleic Acid Testing Market Size Analysis, by Others Indications, 2017–2027

Figure 128: Eastern Europe Nucleic Acid Testing Market Size Analysis, by Hospitals, 2012–2016

Figure 129: Eastern Europe Nucleic Acid Testing Market Forecast, by Hospitals, 2017–2027

Figure 130: Eastern Europe Nucleic Acid Testing Market Size Analysis, by Pathology Laboratories, 2012–2016

Figure 131: Eastern Europe Nucleic Acid Testing Market Forecast, by Pathology Laboratories, 2017–2027

Figure 132: Eastern Europe Nucleic Acid Testing Market Size Analysis, by Research Institutes, 2012–2016

Figure 133: Eastern Europe Nucleic Acid Testing Market Forecast, by Research Institutes, 2017–2027

Figure 134: Eastern Europe Nucleic Acid Testing Market Size Analysis, by Clinics, 2012–2016

Figure 135: Eastern Europe Nucleic Acid Testing Market Forecast, by Clinics, 2017–2027

Figure 136: Eastern Europe Nucleic Acid Testing Market Attractiveness Analysis, By Country

Figure 137: Latin Nucleic Acid Testing Market Attractiveness Analysis, By Product Type

Figure 138: Latin Nucleic Acid Testing Market Attractiveness Analysis, By Indication

Figure 139: Latin Nucleic Acid Testing Market Attractiveness Analysis, By End User

Figure 140: APECJ Nucleic Acid Testing Market Size Analysis, 2012–2016

Figure 141: APECJ Nucleic Acid Testing Market Forecast, 2017–2027

Figure 142: India Nucleic Acid Testing Market Size Analysis, 2012–2016

Figure 143: India Nucleic Acid Testing Market Forecast, 2017–2027

Figure 144: Australia & New Zealand Nucleic Acid Testing Market Size Analysis, 2012–2016

Figure 145: Australia & New Zealand Nucleic Acid Testing Market Forecast, 2017–2027

Figure 146: ASEAN Nucleic Acid Testing Market Size Analysis, 2012–2016

Figure 147: ASEAN Nucleic Acid Testing Market Forecast, 2017–2027

Figure 148: Rest of APECJ Nucleic Acid Testing Market Size Analysis, 2012–2016

Figure 149: Rest of APECJ Nucleic Acid Testing Market Forecast, 2017–2027

Figure 150: APECJ Nucleic Acid Testing Market Size Analysis, by Nucleic Acid test Kits, 2012–2016

Figure 151: APECJ Nucleic Acid Testing Market Forecast, by Nucleic Acid test Kits, 2017–2027

Figure 152: APECJ Nucleic Acid Testing Market Size Analysis, by Consumables, 2012–2016

Figure 153: APECJ Nucleic Acid Testing Market Forecast, by Consumables, 2017–2027

Figure 154: APECJ Nucleic Acid Testing Market Size Analysis, by Infectious Diseases, 2012–2016

Figure 155: APECJ Nucleic Acid Testing Market Forecast, by Infectious Diseases, 2017–2027

Figure 156: APECJ Nucleic Acid Testing Market Size Analysis, by Cancer, 2012–2016

Figure 157: APECJ Nucleic Acid Testing Market Forecast, by Cancer, 2017–2027

Figure 158: APECJ Nucleic Acid Testing Market Size Analysis, by Forensic Testing, 2012–2016

Figure 159: APECJ Nucleic Acid Testing Market Forecast, by Forensic Testing, 2017–2027

Figure 160: APECJ Nucleic Acid Testing Market Size Analysis, Other Indication, 2012–2016

Figure 161: APECJ Nucleic Acid Testing Market Size Analysis, by Other Indication, 2017–2027

Figure 162: APECJ Nucleic Acid Testing Market Size Analysis, by Hospitals, 2012–2016

Figure 163: APECJ Nucleic Acid Testing Market Forecast, by Hospitals, 2017–2027

Figure 164: APECJ Nucleic Acid Testing Market Size Analysis, by Pathology Laboratories, 2012–2016

Figure 165: APECJ Nucleic Acid Testing Market Forecast, by Pathology Laboratories, 2017–2027

Figure 166: APECJ Nucleic Acid Testing Market Size Analysis, by Research Institutes, 2012–2016

Figure 167: APECJ Nucleic Acid Testing Market Forecast, by Research Institutes, 2017–2027

Figure 168: APECJ Nucleic Acid Testing Market Size Analysis, by Clinics, 2012–2016

Figure 169: APECJ Nucleic Acid Testing Market Forecast, by Clinics, 2017–2027

Figure 170: APECJ Nucleic Acid Testing Market Attractiveness Analysis, By Country

Figure 171: Latin Nucleic Acid Testing Market Attractiveness Analysis, By Product Type

Figure 172: Latin Nucleic Acid Testing Market Attractiveness Analysis, By Indication

Figure 173: Latin Nucleic Acid Testing Market Attractiveness Analysis, By End User

Figure 174: China Nucleic Acid Testing Market Size Analysis, 2012–2016

Figure 175: China Nucleic Acid Testing Market Forecast, 2017–2027

Figure 176: China Nucleic Acid Testing Market Size Analysis, by Nucleic Acid test Kits, 2012–2016

Figure 177: China Nucleic Acid Testing Market Forecast, by Nucleic Acid test Kits, 2017–2027

Figure 178: China Nucleic Acid Testing Market Size Analysis, by Consumables, 2012–2016

Figure 179: China Nucleic Acid Testing Market Forecast, by Consumables, 2017–2027

Figure 180: China Nucleic Acid Testing Market Size Analysis, by Infectious Diseases, 2012–2016

Figure 181: China Nucleic Acid Testing Market Forecast, by Infectious Diseases, 2017–2027

Figure 182: China Nucleic Acid Testing Market Size Analysis, by Cancer, 2012–2016

Figure 183: China Nucleic Acid Testing Market Forecast, by Cancer, 2017–2027

Figure 184: China Nucleic Acid Testing Market Size Analysis, by Forensic Testing, 2012–2016

Figure 185: China Nucleic Acid Testing Market Forecast, by Forensic Testing, 2017–2027

Figure 186: China Nucleic Acid Testing Market Size Analysis, by Others Indications, 2012–2016

Figure 187: China Nucleic Acid Testing Market Size Analysis, by Others Indications, 2017–2027

Figure 188: China Nucleic Acid Testing Market Size Analysis, by Hospitals, 2012–2016

Figure 189: China Nucleic Acid Testing Market Forecast, by Hospitals, 2017–2027

Figure 190: China Nucleic Acid Testing Market Size Analysis, by Pathology Laboratories, 2012–2016

Figure 191: China Nucleic Acid Testing Market Forecast, by Pathology Laboratories, 2017–2027

Figure 192: China Nucleic Acid Testing Market Size Analysis, by Research Institutes, 2012–2016

Figure 193: China Nucleic Acid Testing Market Forecast, by Research Institutes, 2017–2027

Figure 194: China Nucleic Acid Testing Market Size Analysis, by Clinics, 2012–2016

Figure 195: China Nucleic Acid Testing Market Forecast, by Clinics, 2017–2027

Figure 196: China Nucleic Acid Testing Market Attractiveness Analysis, By Product Type

Figure 197: China Nucleic Acid Testing Market Attractiveness Analysis, By Indication

Figure 198: China Nucleic Acid Testing Market Attractiveness Analysis, By End User

Figure 199: Japan Nucleic Acid Testing Market Size Analysis, 2012–2016

Figure 200: Japan Nucleic Acid Testing Market Forecast, 2017–2027

Figure 201: Japan Nucleic Acid Testing Market Size Analysis, by Nucleic Acid test Kits, 2012–2016

Figure 202: Japan Nucleic Acid Testing Market Forecast, by Nucleic Acid test Kits, 2017–2027

Figure 203: Japan Nucleic Acid Testing Market Size Analysis, by Consumables, 2012–2016

Figure 204: Japan Nucleic Acid Testing Market Forecast, by Consumables, 2017–2027

Figure 205: Japan Nucleic Acid Testing Market Size Analysis, by Infectious Diseases, 2012–2016

Figure 206: Japan Nucleic Acid Testing Market Forecast, Infectious Diseases, 2017–2027

Figure 207: Japan Nucleic Acid Testing Market Size Analysis, by Cancer, 2012–2016

Figure 208: Japan Nucleic Acid Testing Market Forecast, by Cancer, 2017–2027

Figure 209: Japan Nucleic Acid Testing Market Size Analysis, by Forensic Testing, 2012–2016

Figure 210: Japan Nucleic Acid Testing Market Forecast, by Forensic Testing, 2017–2027

Figure 211: Japan Nucleic Acid Testing Market Size Analysis, by Others Indications, 2012–2016

Figure 212: Japan Nucleic Acid Testing Market Size Analysis, by Others Indications, 2017–2027

Figure 213: Japan Nucleic Acid Testing Market Size Analysis, by Hospitals, 2012–2016

Figure 214: Japan Nucleic Acid Testing Market Forecast, by Hospitals, 2017–2027

Figure 215: Japan Nucleic Acid Testing Market Size Analysis, by Pathology Laboratories, 2012–2016

Figure 216: Japan Nucleic Acid Testing Market Forecast, by Pathology Laboratories, 2017–2027

Figure 217: Japan Nucleic Acid Testing Market Size Analysis, by y Research Institutes, 2012–2016

Figure 218: Japan Nucleic Acid Testing Market Forecast, by Research Institutes, 2017–2027

Figure 219: Japan Nucleic Acid Testing Market Size Analysis, by Clinics, 2012–2016

Figure 220: Japan Nucleic Acid Testing Market Forecast, by Clinics, 2017–2027

Figure 221: Japan Nucleic Acid Testing Market Attractiveness Analysis, By Product Type

Figure 222: Japan Nucleic Acid Testing Market Attractiveness Analysis, By Indication

Figure 223: Japan Nucleic Acid Testing Market Attractiveness Analysis, By End User

Figure 224: MEA Nucleic Acid Testing Market Size Analysis, 2012–2016

Figure 225: MEA Nucleic Acid Testing Market Forecast, 2017–2027

Figure 226: GCC Countries Nucleic Acid Testing Market Size Analysis, 2012–2016

Figure 227: GCC Countries Nucleic Acid Testing Market Forecast, 2017–2027

Figure 228: South Africa Nucleic Acid Testing Market Size Analysis, 2012–2016

Figure 229: South Africa Nucleic Acid Testing Market Forecast, 2017–2027

Figure 230: Rest of MEA Nucleic Acid Testing Market Size Analysis, 2012–2016

Figure 231: Rest of MEA Nucleic Acid Testing Market Size Analysis, 2017–2027

Figure 232: MEA Nucleic Acid Testing Market Size Analysis, by Nucleic Acid test Kits, 2012–2016

Figure 233: MEA Nucleic Acid Testing Market Forecast, by Nucleic Acid test Kits, 2017–2027

Figure 234: MEA Nucleic Acid Testing Market Size Analysis, by Consumables, 2012–2016

Figure 235: MEA Nucleic Acid Testing Market Forecast, by Consumables, 2017–2027

Figure 236: MEA Nucleic Acid Testing Market Size Analysis, by Infectious Diseases, 2012–2016

Figure 237: MEA Nucleic Acid Testing Market Forecast, by Infectious Diseases, 2017–2027

Figure 238: MEA Nucleic Acid Testing Market Size Analysis, by Cancer, 2012–2016

Figure 239: MEA Nucleic Acid Testing Market Forecast, by Cancer, 2017–2027

Figure 240: MEA Nucleic Acid Testing Market Size Analysis, by Forensic Testing, 2012–2016

Figure 241: MEA Nucleic Acid Testing Market Forecast, by Forensic Testing, 2017–2027

Figure 242: MEA Nucleic Acid Testing Market Size Analysis, by Others Indications, 2012–2016

Figure 243: MEA Nucleic Acid Testing Market Size Analysis, by Others Indications, 2017–2027

Figure 244: MEA Nucleic Acid Testing Market Size Analysis, by Hospitals, 2012–2016

Figure 245: MEA Nucleic Acid Testing Market Forecast, by Hospitals, 2017–2027

Figure 246: MEA Nucleic Acid Testing Market Size Analysis, by Pathology Laboratories, 2012–2016

Figure 247: MEA Nucleic Acid Testing Market Forecast, by Pathology Laboratories, 2017–2027

Figure 248: MEA Nucleic Acid Testing Market Size Analysis, by Research Institutes, 2012–2016

Figure 249: MEA Nucleic Acid Testing Market Forecast, by Research Institutes, 2017–2027

Figure 250: MEA Nucleic Acid Testing Market Size Analysis, by Clinics, 2012–2016

Figure 251: MEA Nucleic Acid Testing Market Forecast, by Clinics, 2017–2027

Figure 252: MEA Nucleic Acid Testing Market Attractiveness Analysis, By Country

Figure 253: Latin Nucleic Acid Testing Market Attractiveness Analysis, By Product Type

Figure 254: Latin Nucleic Acid Testing Market Attractiveness Analysis, By Indication

Figure 255: Latin Nucleic Acid Testing Market Attractiveness Analysis, By End User

Figure 256: Global Nucleic Acid Testing Market Attractiveness Analysis By Region, 2017–2027 

Figure 257: Global Nucleic Acid Testing Market Attractiveness Analysis By Product Type, 2017–2027 

Figure 258: Global Nucleic Acid Testing Market Attractiveness Analysis By Indication, 2017–2027 

Figure 259: Global Nucleic Acid Testing Market Attractiveness Analysis By End User, 2017–2027 

Figure 260: Global Nucleic Acid Testing Market Value Analysis and Forecast, 2016–2027 (US$ Mn)

Figure 261: Global Nucleic Acid Testing Market Absolute $ Opportunity (US$ Mn), 2012–2016

Figure 262: Global Nucleic Acid Testing Market Absolute $ Opportunity (US$ Mn), 2016–2027